Form D · Other Health Care
OmniBuds, Inc.
Nashville, TN · CIK 0002158873
Offering snapshot reported Oct 21, 2026 · SEC filing
- Reported sold
- $3M Offering amount: $14.6M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 11, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2026 | Initial | $2,999,991 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-602040
Source: Form D, filed Oct 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Caradonna | Director |
| Benedict Carter | Director, Executive |
| James Hayward | Director |
| Chris D. Jones | Director |
| Jeffrey Karras | Director |
| Fahim Kawsaar | Director |
| James Stefansic | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1005 17th Ave S, Suite 900
Nashville, TN, 37212
Nashville, TN, 37212